Explore the essential ‘International Regulatory Requirements for Bioequivalence’ in Genetic Drug Product Development Drugs And The Pharm Sci Vol 201. This crucial volume from The Bookish Owl addresses the global surge in generic and multi-source drug products, driven by the need for affordable therapies. Learn how to navigate complex national and international laws to ensure quality and therapeutic equivalence to brand-name alternatives. Essential for pharmaceutical scientists and regulatory professionals, this book details worldwide legislative frameworks, critical for drug product registration and market access, especially in countries with limited inspection resources. Optimize your drug development strategy with this indispensable guide.